Genome editing is the effective and precise modification of DNA in the cell. The technique comprises making cuts at particular DNA sequences having enzymes that are known as engineered nucleases. Genome editing technique is used to remove, add, or modify DNA in the genome, which helps to change the characteristics of an organism or cell. Genome editing is used in three major applications; for disease treatment, for research, and in biotechnology. In research, the technique is used to understand the biology of cells or organisms. In biotechnology, the said technique performs efficiently in order to improve crop production. In the treatment of diseases, the targeted technique is used to alter human blood cells for curing AIDS or leukaemia. Genome editing is also expected to cure disorders like haemophilia and muscular dystrophy.
Market Industry Reports (MIR) has published a new report titled "Genome Editing/Genome Engeineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report the global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is anticipated to grow at a CAGR of 14.1% from 2019 to 2030.Major Key Players of the Genome Editing/Genome Engineering Market are:
Thermo Fisher Scientific, Lonza, Merck, Horizon Discovery Group, Integrated DNA Technologies, New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.
No comments:
Post a Comment